Home » Authors » Kim Coghill

Articles by Kim Coghill

FDA Panel Discusses Endpoints For Approval Of Gout Products

June 3, 2004

FDA Panel Discusses Endpoints For Approval Of Gout Products

June 3, 2004

Serono Starts Phase III Trial Of Serostim In HARS Patients

June 2, 2004

SuperGen Submits First Part Of Rolling NDA For Dacogen

June 2, 2004

SuperGen Submits First Part Of Rolling NDA For Dacogen

June 2, 2004

Serono Starts Phase III Trial Of Serostim In HARS Patients

June 2, 2004

Avigen Stops Coagulin-B Phase I, Plans Drug's Future With Bayer

June 1, 2004

Avigen Stops Coagulin-B Phase I, Plans Drug's Future With Bayer

June 1, 2004

Syrrx Receives Milestone From Biogen Idec In Target Agreement

May 28, 2004

With MyVax In Phase III, Genitope Raising $51.8M In Public Offering

May 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...